What are the recommendations for hepatitis A and B vaccination in pregnant women at high risk of exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis Vaccination in Pregnancy

Direct Recommendation

Pregnant women at high risk for hepatitis B infection should receive the hepatitis B vaccine during pregnancy, as it is safe and does not increase adverse pregnancy outcomes. 1, 2 Hepatitis A vaccine can also be safely administered to pregnant women at risk of exposure. 1

Hepatitis B Vaccination in Pregnancy

Who Should Be Vaccinated

Pregnant women meeting any of the following high-risk criteria should receive hepatitis B vaccination 1, 2:

  • More than one sex partner during the previous 6 months 1
  • Evaluation or treatment for a sexually transmitted infection 1
  • Recent or current injection-drug use 1
  • HBsAg-positive sex partner 1
  • Any pregnant patient who requests the vaccine can be offered vaccination 2

The CDC and ACOG are clear that acknowledgment of specific risk factors should not be a requirement—any pregnant woman at risk or requesting protection should be vaccinated. 1, 2

Vaccination Schedule and Timing

  • Standard 3-dose series (0,1, and 6 months) should be initiated during pregnancy for those who test negative but have risk factors 2
  • An accelerated schedule (0,1, and 4 months) has been shown effective and can be completed during pregnancy, with 90% seroconversion rates after three doses 3
  • Do not delay vaccination while assessing risk factors 2

Safety Profile

The hepatitis B vaccine has an excellent safety record in pregnancy 2, 4:

  • No increased risk of gestational hypertension, gestational diabetes, pre-eclampsia, cesarean delivery, preterm delivery, low birthweight, or small for gestational age infants 4
  • No congenital abnormalities observed even with first-trimester exposure 5
  • Most common side effect is injection site discomfort (10.5% of recipients) 3
  • Seroconversion rates are high (90-100%), though body mass index is inversely associated with response 3

Critical Distinction: Maternal vs. Neonatal Protection

Important caveat: The vaccine does NOT prevent infant infection from maternal transmission if the mother is already HBsAg-positive. 2 The vaccine's purpose is to protect the mother from acquiring HBV infection during pregnancy. 2 Infants born to HBsAg-positive mothers require both HBIG and vaccine within 12 hours of birth for protection. 1, 2

Hepatitis A Vaccination in Pregnancy

Indications

Vaccination of pregnant women identified to be at risk for hepatitis A infection during pregnancy is recommended. 1

Safety and Options

  • Both hepatitis A vaccine and immunoglobulin for postexposure prophylaxis can be used in pregnancy 1
  • The EASL guidelines (2023) provide 100% consensus support for this recommendation 1

Universal Screening Requirements

Regardless of vaccination status, all pregnant women should be tested for HBsAg during the first trimester of each pregnancy, even if previously vaccinated or tested. 1, 2 This is critical because:

  • Testing identifies chronically infected women who need antiviral therapy consideration 1
  • Ensures infants of HBsAg-positive mothers receive timely prophylaxis 1
  • Women not tested prenatally or with high-risk behaviors should be tested at hospital admission for delivery 1

Counseling Beyond Vaccination

Pregnant women at risk should be counseled on additional prevention methods beyond vaccination, including avoidance of high-risk behaviors and exposure reduction strategies. 1, 2

Implementation in Clinical Practice

Healthcare providers should implement standing orders to identify and vaccinate pregnant women at risk as part of routine prenatal services. 1 The low uptake observed in real-world data (2.1 per 1000 pregnancies) suggests significant underutilization despite clear safety and efficacy data. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis B Vaccination During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatitis B vaccine in pregnancy: maternal and fetal safety.

American journal of perinatology, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.